In what is believed to be a world’s first, Shanghai, China’s commercial capital, introduced a new type of COVID-19 vaccine that would be inhaled rather than administer via injection. In addition to this, these vaccines are approved by Chinese pharmaceutical firm “CanSino Biologics”, for use as a booster in September. “Our body’s first line of defence is the mucus membrane of our respiratory system, we want that to be directly stimulated to improve immunity and using the inhaled vaccine does that,” Dr. Zhao Hui.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Two-day pharma and healthcare expo kickstarts

Lahore: Pak Pharma and Healthcare expo in collaboration with the Pakistan Pharmaceutical…

Global groups propose pandemic plan

Chicago: On April 5, four organizations focused on global health and the…

Abu Dhabi aquarium to host exhibition on healing oceans

It emerged that the National Aquarium in Al Qana would host an…